港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

晶泰控股-P

4.350

-0.150-3.33%

成交量：2,729.32万

成交额：1.20亿

市值：174.87亿

市盈率：-5.11

高：4.510

开：4.510

低：4.330

收：4.500

数据加载中...

总览公司新闻资讯公告

晶泰控股-P(02228)预期2024年度将达到已商业化公司的收入门槛

晶泰控股-P02月14日主力大幅流入1.02亿元散户资金抛售

【港股异动 | 晶泰控股-P(02228.HK)午后涨超9%】晶泰控股-P(02228.HK)午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。

港股异动 | 晶泰控股-P(02228)午后涨超9% AI制药潜力巨大公司近期与韩国药企JW达成战略合作

“AI+医疗”概念火热并获多方看好相关股份集体走高医渡科技(02158)涨10.38%

异动解读 | 晶泰控股盘中大涨5.12% 或因AI驱动医疗健康板块新机遇

晶泰控股-P盘中异动股价大涨5.12%

【券商聚焦】交银国际指AI技术驱动医药板块新机遇关注AI相关的创新和估值修复机会

晶泰控股-P02月13日遭主力抛售9294万元

晶泰控股-P盘中异动早盘急速下跌5.12%

晶泰控股－Ｐ(02228)出现大手卖出75.8万股，成交价$6.44，涉资488.152万

阿斯达克财经

港股异动 | 晶泰控股-P(02228)再涨超6% AI制药领域持续蓬勃发展行业有望进入“质变”阶段

异动解读 | 南向资金增持引领晶泰控股-P盘中大涨5%

晶泰控股-P盘中异动早盘大幅拉升5.07%

南向资金2月11日净买入晶泰控股-P959.10万股连续3日增持

国投证券：AI制药迎来“质变”阶段商业化应用落地可期

晶泰控股－Ｐ(02228)出现大手卖出97万股，成交价$6.7，涉资649.9万

阿斯达克财经

【港股异动 | 晶泰控股-P(02228.HK)午前涨超13%】晶泰控股-P(02228.HK)午前涨超13%，截至发稿，涨13.37%，报6.7港元，成交额14.1亿港元。

港股异动 | 晶泰控股-P(02228)午前涨超13% 宣布战略投资或然生物共同推进首创新药研发

港股异动 | AI医疗概念股早盘走强 AI赋能医药医疗不断取得新进展多家医疗公司表态接入DeepSeek

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02228/news?page=9"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02228","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","market":"HK","secType":"STK","nameCN":"晶泰控股-P","latestPrice":4.35,"timestamp":1747280087804,"preClose":4.5,"halted":0,"volume":27293208,"delay":0,"floatShares":4020000000,"shares":4020000000,"eps":-0.8514864421784111,"marketStatus":"交易中","change":-0.15,"latestTime":"05-15 11:34:48","open":4.51,"high":4.51,"low":4.33,"amount":119649106,"amplitude":0.04,"askPrice":4.35,"askSize":41000,"bidPrice":4.34,"bidSize":184000,"shortable":3,"etf":0,"ttmEps":-0.8557783330080032,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1747281600000},"marketStatusCode":2,"adr":0,"listingDate":1718208000000,"exchange":"SEHK","adjPreClose":4.5,"openAndCloseTimeList":[[1747272600000,1747281600000],[1747285200000,1747296000000]],"volumeRatio":1.252543,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02228\",,,,,undefined,":{"symbol":"02228","floatShares":4020000000,"roa":"-10.69%","roe":"--","lyrEps":-0.851486,"volumeRatio":1.252543,"shares":4020000000,"dividePrice":0,"high":4.51,"amplitude":0.04,"preClose":4.5,"low":4.33,"week52Low":3.05,"pbRate":"4.07","psRate":"60.59","week52High":16.2,"institutionHeld":0,"latestPrice":4.35,"committee":0.635556,"eps":-0.8514864421784111,"divideRate":0,"volume":27293208,"delay":0,"ttmEps":-0.8557783330080032,"open":4.51,"prevYearClose":5.98,"prevWeekClose":4.63,"prevMonthClose":5.16,"prevQuarterClose":5.89,"fiveDayClose":4.7,"twentyDayClose":4.65,"sixtyDayClose":6.05},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02228\",pageSize:20,pageCount:9,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2512921965","title":"晶泰控股-P(02228)预期2024年度将达到已商业化公司的收入门槛","url":"https://stock-news.laohu8.com/highlight/detail?id=2512921965","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2512921965?lang=zh_cn&edition=fundamental","pubTime":"2025-02-17 08:04","pubTimestamp":1739750670,"startTime":"0","endTime":"0","summary":"智通财经APP讯，晶泰控股-P(02228)发布公告，集团预期截至2024年12月31日止年度透过提供药物发现解决方案及智能自动化解决方案所产生的收入将达到已商业化公司(定义见上市规则第18C章)的收入门槛，即2.5亿港元。该等收入乃由于本集团于截至2024年12月31日止年度的业务发展及市场机遇所致。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1250411.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2511656700","title":"晶泰控股-P02月14日主力大幅流入1.02亿元 散户资金抛售","url":"https://stock-news.laohu8.com/highlight/detail?id=2511656700","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511656700?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 16:17","pubTimestamp":1739521035,"startTime":"0","endTime":"0","summary":"02月14日, 晶泰控股-P股价涨9.26%，报收6.61元，成交金额16.91亿元，换手率7.07%，振幅13.55%，量比1.35。晶泰控股-P今日主力资金净流入1.02亿元，上一交易日主力净流出9294万元。该股近5个交易日上涨9.64%，主力资金累计净流入6448万元；近20日主力资金累计净流入2.27亿元，其中净流入天数为10日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214161850a2459cc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214161850a2459cc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":1},{"id":"2511639994","title":"【港股异动 | 晶泰控股-P(02228.HK)午后涨超9%】晶泰控股-P(02228.HK)午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2511639994","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511639994?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 14:11","pubTimestamp":1739513494,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228.HK)午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/14141148160619.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2511586639","title":"港股异动 | 晶泰控股-P(02228)午后涨超9% AI制药潜力巨大 公司近期与韩国药企JW达成战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=2511586639","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511586639?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 14:08","pubTimestamp":1739513301,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股-P午后涨超9%，截至发稿，涨7.11%，报6.48港元，成交额10.34亿港元。建议关注AI制药，如晶泰控股-P等。此外，晶泰科技近期宣布，与亚洲领先的韩国药企JW Pharmaceutical签署千万级人民币的战略合作协议。此次与JW的合作，标志着晶泰科技自动化实验室解决方案首次获得海外药企客户的采购，具有重要的里程碑意义。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1249827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","01477","02228","BK1191","BK1574"],"gpt_icon":1},{"id":"2511686533","title":"“AI+医疗”概念火热并获多方看好 相关股份集体走高 医渡科技(02158)涨10.38%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511686533","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511686533?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 09:52","pubTimestamp":1739497955,"startTime":"0","endTime":"0","summary":"金吾财讯 | “AI+医疗”概念火热，医渡科技 涨10.38%，信达生物涨5.3%，晶泰控股涨3.97%，讯飞医疗科技涨3.07%，鹰瞳科技跟涨。交银国际表示，AI大模型赋能数字医疗服务公司，在疾病诊断/检测方面潜力显着。另外，高盛此前在2025年国际消费类电子产品展览会数字医疗健康专场中，即点明“AI+医疗”将成为该行业吸引全球资金最核心的投资主题。","market":"nz","thumbnail":"https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20200908/MDgxZGVmMDU5NGQxM2FkZGQzODVkYTY4OWM4NjkxNzk5NzY4NzQ2MDU0.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953143","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","02158","BK1141","BK1161","BK1589","02228","02506","02251","BK1583","LU2488822045.USD","LU2328871848.SGD","BK1189","159891","LU1969619763.USD","BK1518"],"gpt_icon":0},{"id":"1127190908","title":"异动解读 | 晶泰控股盘中大涨5.12% 或因AI驱动医疗健康板块新机遇","url":"https://stock-news.laohu8.com/highlight/detail?id=1127190908","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1127190908?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 09:42","pubTimestamp":1739497374,"startTime":"0","endTime":"0","summary":"今日盘中,晶泰控股(02228)股价大涨5.12%,引发了市场的广泛关注。\n\n据相关报道,交银国际指出,多家医药公司接入DeepSeek AI模型,AI加医疗加速落地。消费级医疗健康公司如晶泰控股所属的医渡科技(02158)等宣布接入DeepSeek模型,有望在疾病诊断、电子病历等领域获得AI赋能,提升服务效率。同时,AI大模型也可助力医药研发,提高药物设计效率,利好创新药企和CRO公司。\n\n交银国际预计,在财政和医保利好政策的持续利好下,医药健康板块整体仍有较大估值修复空间,建议重点关注拥有AI应用场景优势的相关公司,如医渡科技、晶泰控股等。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 晶泰控股盘中大涨5.12% 或因AI驱动医疗健康板块新机遇","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2511683653","title":"晶泰控股-P盘中异动 股价大涨5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511683653","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511683653?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 09:41","pubTimestamp":1739497265,"startTime":"0","endTime":"0","summary":"2025年02月14日早盘09时41分，晶泰控股-P股票出现波动，股价快速上涨5.12%。截至发稿，该股报6.360港元/股，成交量1953.6万股，换手率0.53%，振幅4.13%。资金方面，该股资金流入6134.56万港元，流出3415.12万港元。晶泰控股-P股票所在的生物技术行业中，整体涨幅为1.11%。晶泰控股-P公司简介：晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214094105abce3c70&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214094105abce3c70&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2511500266","title":"【券商聚焦】交银国际指AI技术驱动医药板块新机遇 关注AI相关的创新和估值修复机会","url":"https://stock-news.laohu8.com/highlight/detail?id=2511500266","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511500266?lang=zh_cn&edition=fundamental","pubTime":"2025-02-14 09:12","pubTimestamp":1739495546,"startTime":"0","endTime":"0","summary":"国家医保局发文提及江西省结算改革成果，医药供货企业回款周期已由半年减至30天。该行指，AI大模型赋能数字医疗服务公司，在疾病诊断/检测方面潜力显着。同时，能助力医药研发提高效率、优化药物设计，利好CRO和创新药企。结合后续财政和医保/商保利好政策有望继续出台、整体板块估值仍处历史底部，该行认为板块仍有较大修复空间。","market":"other","thumbnail":"https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ODRhMzI4MWM5YTc2MTY1NjgxNGQwMTEwODUwOTcyNzQ0Mg==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1953133","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01952","LU0348783233.USD","LU1794554557.SGD","LU0417516571.SGD","01177","LU0348784397.USD","159938","09939","BK1191","02228","BK1574","03329","BK1189","BK1515","02096","LU2488822045.USD","BK1518","09926","02158","01801","LU2328871848.SGD","02251","03692","02506","162414","BK1161","BK1583","BK1521","IE00B543WZ88.USD","IE00B5MMRT66.SGD","IE00BPRC5H50.USD","BK1589","BK1147","LU1720050803.USD","LU1969619763.USD","BK1141"],"gpt_icon":0},{"id":"2511518130","title":"晶泰控股-P02月13日遭主力抛售9294万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2511518130","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511518130?lang=zh_cn&edition=fundamental","pubTime":"2025-02-13 16:17","pubTimestamp":1739434623,"startTime":"0","endTime":"0","summary":"02月13日, 晶泰控股-P股价跌6.06%，报收6.05元，成交金额9.76亿元，换手率4.25%，振幅10.87%，量比0.77。晶泰控股-P今日主力资金净流出9294万元，连续3日净流出，上一交易日主力净流出922万元。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为16.67%，平均跌幅为0.41%。该股近5个交易日上涨0.83%，主力资金累计净流出6480万元；近20日主力资金累计净流入1.23亿元，其中净流入天数为9日。该股主力净额占比0.42%，港股市场排名2647/2650。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213161957abcd57b6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213161957abcd57b6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":1},{"id":"2511550881","title":"晶泰控股-P盘中异动 早盘急速下跌5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511550881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2511550881?lang=zh_cn&edition=fundamental","pubTime":"2025-02-13 10:41","pubTimestamp":1739414470,"startTime":"0","endTime":"0","summary":"2025年02月13日早盘10时41分，晶泰控股-P股票出现异动，股价急速下挫5.12%。截至发稿，该股报6.110港元/股，成交量5862.2万股，换手率1.59%，振幅9.32%。资金方面，该股资金流入1.21349亿港元，流出1.93023亿港元。晶泰控股-P股票所在的生物技术行业中，整体涨幅为0.12%。晶泰控股-P公司简介：晶泰控股有限公司是一家主要从事为制药及材料科学等产业提供药物及材料科学研发解决方案及服务的控股公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213104110a243f9eb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250213104110a243f9eb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1141","02228"],"gpt_icon":1},{"id":"2510650326","title":"晶泰控股－Ｐ(02228)出现大手卖出75.8万股，成交价$6.44，涉资488.152万","url":"https://stock-news.laohu8.com/highlight/detail?id=2510650326","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510650326?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 16:08","pubTimestamp":1739347680,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在下午04:08出现大手卖出，成交量为75.8万，成交价为港币$6.44，涉资488.152万。至目前为止，股价跌3.881%，今日最高价为$7.18，而最低价为$6.02，总成交量为2.284亿股，总成交金额港币$15.287亿。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145550868_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAV2502128769/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["02228","BK1141"],"gpt_icon":0},{"id":"2510969673","title":"港股异动 | 晶泰控股-P(02228)再涨超6% AI制药领域持续蓬勃发展 行业有望进入“质变”阶段","url":"https://stock-news.laohu8.com/highlight/detail?id=2510969673","media":"智通财经","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510969673?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 09:51","pubTimestamp":1739325093,"startTime":"0","endTime":"0","summary":"国投证券发布研报称，受加速药物研发的需求增加、AI应用领域的拓展、配套政策的支持等多因素驱动，近年AI制药领域持续蓬勃发展。随着AI主导的药物研发项目的成功率提升、相关研发管线持续取得进展，AI制药技术的进一步商业化应用值得期待。AI制药技术的应用有望缩短药物研发周期，降低成本，提高研发成功率。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248691.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1191","01477","BK1141","BK1574","02228"],"gpt_icon":1},{"id":"1174734607","title":"异动解读 | 南向资金增持引领 晶泰控股-P盘中大涨5%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174734607","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1174734607?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 09:45","pubTimestamp":1739324719,"startTime":"0","endTime":"0","summary":"2月12日早盘,晶泰控股-P(股份代号02228)股价盘中大涨5.07%,引起市场广泛关注。\n\n公开数据显示,2月11日南向资金大幅增持晶泰控股-P959.1万股,为连续第3天净买入该股票。截至上周五收盘,南向资金共持有该股6.78亿股,占流通股18.43%。\n\n分析认为,南向资金的持续增持行为,体现了海外投资者对晶泰控股-P未来发展前景的信心,这是推动该股今日上涨的主要动力。与此同时,该股在近期也保持了不错的上涨行情,在获利盘撤离下,吸引更多资金进场介入。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"异动解读 | 南向资金增持引领 晶泰控股-P盘中大涨5%","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["02228"],"gpt_icon":0},{"id":"2510203396","title":"晶泰控股-P盘中异动 早盘大幅拉升5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510203396","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510203396?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 09:43","pubTimestamp":1739324584,"startTime":"0","endTime":"0","summary":"2025年02月12日早盘09时43分，晶泰控股-P股票出现波动，股价快速上涨5.07%。截至发稿，该股报7.040港元/股，成交量1927.8万股，换手率0.52%，振幅5.07%。晶泰控股-P股票所在的生物技术行业中，整体跌幅为0.15%。其相关个股中，北海康成-B、科笛-B、迈博药业-B涨幅较大，振幅较大的相关个股有科笛-B、科伦博泰生物-B、晶泰控股-P，振幅分别为12.03%、5.46%、4.93%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212094304abcb98dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212094304abcb98dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":1},{"id":"2510664395","title":"南向资金2月11日净买入晶泰控股-P959.10万股 连续3日增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2510664395","media":"市场透视","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510664395?lang=zh_cn&edition=fundamental","pubTime":"2025-02-12 09:30","pubTimestamp":1739323825,"startTime":"0","endTime":"0","summary":"2月11日, 南向资金增持晶泰控股-P959.10万股，连续3日增持。截止当日收盘，港股通共持有晶泰控股-P67809.62万股，占流通股18.43%。晶泰控股-P近5个交易日上涨24.54%，港股通累计增持13923.27万股；近20个交易日上涨39.58%，港股通累计增持19239.07万股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212093311abcb955a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250212093311abcb955a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02228","BK1141"],"gpt_icon":1},{"id":"2510387394","title":"国投证券：AI制药迎来“质变”阶段 商业化应用落地可期","url":"https://stock-news.laohu8.com/highlight/detail?id=2510387394","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510387394?lang=zh_cn&edition=fundamental","pubTime":"2025-02-11 14:50","pubTimestamp":1739256607,"startTime":"0","endTime":"0","summary":"国投证券主要观点如下：多因素驱动AI制药蓬勃发展，行业有望进入“质变”阶段：受加速药物研发的需求增加、AI应用领域的拓展、配套政策的支持等多因素驱动，近年AI制药领域持续蓬勃发展。随着AI主导的药物研发项目的成功率提升、相关研发管线持续取得进展，AI制药技术的进一步商业化应用值得期待。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1248241.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK1574","BK1191","01873","02228","01477","BK1576","161027"],"gpt_icon":0},{"id":"2510823213","title":"晶泰控股－Ｐ(02228)出现大手卖出97万股，成交价$6.7，涉资649.9万","url":"https://stock-news.laohu8.com/highlight/detail?id=2510823213","media":"阿斯达克财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510823213?lang=zh_cn&edition=fundamental","pubTime":"2025-02-11 11:58","pubTimestamp":1739246280,"startTime":"0","endTime":"0","summary":"[大手成交]晶泰控股－Ｐ(02228)在上午11:58出现大手卖出，成交量为97万，成交价为港币$6.7，涉资649.9万。至目前为止，股价升0.593%，今日最高价为$6.99，而最低价为$6.62，总成交量为8.653千万股，总成交金额港币$5.883亿。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205145552499_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAT2502115631/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2510538009","title":"【港股异动 | 晶泰控股-P(02228.HK)午前涨超13%】晶泰控股-P(02228.HK)午前涨超13%，截至发稿，涨13.37%，报6.7港元，成交额14.1亿港元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2510538009","media":"金融界","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510538009?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 11:46","pubTimestamp":1739159166,"startTime":"0","endTime":"0","summary":"晶泰控股-P(02228.HK)午前涨超13%，截至发稿，涨13.37%，报6.7港元，成交额14.1亿港元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/10114648042110.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1141","02228"],"gpt_icon":0},{"id":"2510710006","title":"港股异动 | 晶泰控股-P(02228)午前涨超13% 宣布战略投资或然生物 共同推进首创新药研发","url":"https://stock-news.laohu8.com/highlight/detail?id=2510710006","media":"智通财经","labels":["corporation","productRelease","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510710006?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 11:37","pubTimestamp":1739158628,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，晶泰控股-P午前涨超13%，截至发稿，涨13.37%，报6.7港元，成交额14.1亿港元。消息面上，2月10日，晶泰控股-P宣布完成对或然生物的战略投资，并建立深度研发合作。双方正基于或然生物在全球未满足的临床需求领域所发现的First-in-Class靶点，共同推进创新药物研发。目前，或然生物的管线中有多个First-in-Class的在研药物项目，已取得良好的实验数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247617.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,productRelease,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","BK1141","BK1161","02228","159992","BK1574"],"gpt_icon":0},{"id":"2510006497","title":"港股异动 | AI医疗概念股早盘走强 AI赋能医药医疗不断取得新进展 多家医疗公司表态接入DeepSeek","url":"https://stock-news.laohu8.com/highlight/detail?id=2510006497","media":"智通财经","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2510006497?lang=zh_cn&edition=fundamental","pubTime":"2025-02-10 11:31","pubTimestamp":1739158274,"startTime":"0","endTime":"0","summary":"木头姐强调称，医疗保健是最被低估的AI应用。国金证券认为，随着人工智能技术的发展与进步，AI在赋能医药医疗、推动行业升级方面不断取得新进展，人工智能在医药健康领域的应用有望进入加速发展阶段。此外，多家医疗公司近期相继表态接入deepseek。企业有望借助AI进一步提高产品竞争力和客户粘性，巩固行业地位和竞争优势。此外，用好Deepseek等AI工具有助于企业降本增效、改善盈利水平。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1247612.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02228","02158","02252","159938","09955","02192","159891","09939"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":9,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02228\",params:#limit:5,,,undefined,":[{"date":"2025-03-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1743125400000,"name":null,"time":"","dateTimestamp":1743091200000,"actualEps":null},{"date":"2024-08-28","symbol":"02228","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724808600000,"name":null,"time":"","dateTimestamp":1724774400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02228\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02228\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.3333,"buy":0.6667,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6667,"analysts":3,"updateTime":1742313600000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02228\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02228","date":"2025-05-13","current":-8.355545,"percent":0.659193,"low":-19.121462,"twenty":-11.345262,"median":-8.897671,"eighty":-6.784859,"high":-4.071689,"avg":-9.336582,"sd":2.965266,"marketCap":18330341630},"quantilePoints":[{"date":"2024-06-14","current":-8.922014,"twenty":-9.439723,"median":-9.245582,"eighty":-9.051441,"marketCap":18396572909},{"date":"2024-06-21","current":-8.857946,"twenty":-8.9092,"median":-8.775161,"eighty":-8.737522,"marketCap":18226234271},{"date":"2024-06-28","current":-8.745676,"twenty":-8.918198,"median":-8.816527,"eighty":-8.750223,"marketCap":17987760178},{"date":"2024-07-05","current":-8.747576,"twenty":-8.902934,"median":-8.771787,"eighty":-8.744343,"marketCap":17987760178},{"date":"2024-07-12","current":-9.049063,"twenty":-8.902934,"median":-8.775161,"eighty":-8.741587,"marketCap":18635047002},{"date":"2024-07-19","current":-9.247407,"twenty":-9.172529,"median":-8.857489,"eighty":-8.744343,"marketCap":19043859733},{"date":"2024-07-26","current":-9.575773,"twenty":-9.510189,"median":-8.892407,"eighty":-8.745676,"marketCap":19793349741},{"date":"2024-08-02","current":-9.235042,"twenty":-9.509847,"median":-8.912474,"eighty":-8.745676,"marketCap":19077927461},{"date":"2024-08-09","current":-9.468775,"twenty":-9.510189,"median":-8.974725,"eighty":-8.747576,"marketCap":19691146558},{"date":"2024-08-16","current":-10.464009,"twenty":-9.56947,"median":-9.142341,"eighty":-8.760904,"marketCap":21769277942},{"date":"2024-08-23","current":-10.517808,"twenty":-9.632925,"median":-9.235042,"eighty":-8.768412,"marketCap":21973684308},{"date":"2024-08-30","current":-10.371399,"twenty":-10.303269,"median":-9.325095,"eighty":-8.775161,"marketCap":28923500740},{"date":"2024-09-06","current":-18.461728,"twenty":-10.496901,"median":-9.468775,"eighty":-8.776023,"marketCap":51510404146},{"date":"2024-09-13","current":-17.236995,"twenty":-10.891661,"median":-9.521964,"eighty":-8.857032,"marketCap":47967360474},{"date":"2024-09-20","current":-16.063353,"twenty":-11.51195,"median":-9.559061,"eighty":-8.857763,"marketCap":44969400445},{"date":"2024-09-27","current":-15.483466,"twenty":-14.686278,"median":-9.575773,"eighty":-8.860072,"marketCap":43606691340},{"date":"2024-10-04","current":-13.755671,"twenty":-14.947547,"median":-9.615329,"eighty":-8.879685,"marketCap":38564667654},{"date":"2024-10-10","current":-12.348216,"twenty":-14.780027,"median":-9.846626,"eighty":-8.896618,"marketCap":34408404886},{"date":"2024-10-18","current":-11.446606,"twenty":-14.586898,"median":-10.272952,"eighty":-8.910566,"marketCap":31717054404},{"date":"2024-10-25","current":-12.086709,"twenty":-14.247622,"median":-10.371399,"eighty":-8.935918,"marketCap":33488576240},{"date":"2024-11-01","current":-11.046421,"twenty":-13.547793,"median":-10.507354,"eighty":-8.963954,"marketCap":30626887121},{"date":"2024-11-08","current":-8.233542,"twenty":-13.084166,"median":-10.464009,"eighty":-8.959678,"marketCap":22655038860},{"date":"2024-11-15","current":-6.674421,"twenty":-12.818197,"median":-10.331022,"eighty":-8.873325,"marketCap":18226234271},{"date":"2024-11-22","current":-5.092957,"twenty":-12.605094,"median":-9.956054,"eighty":-8.775506,"marketCap":13899632864},{"date":"2024-11-29","current":-4.071689,"twenty":-12.362191,"median":-9.633447,"eighty":-8.746436,"marketCap":11106079200},{"date":"2024-12-06","current":-6.234627,"twenty":-12.309524,"median":-9.607633,"eighty":-8.729287,"marketCap":16965728349},{"date":"2024-12-13","current":-4.937116,"twenty":-12.241743,"median":-9.572622,"eighty":-8.309283,"marketCap":13422684678},{"date":"2024-12-20","current":-6.992956,"twenty":-12.176011,"median":-9.548971,"eighty":-7.374004,"marketCap":18907588823},{"date":"2024-12-27","current":-7.61626,"twenty":-12.099333,"median":-9.521964,"eighty":-6.992956,"marketCap":20576907476},{"date":"2025-01-03","current":-6.613619,"twenty":-12.089234,"median":-9.489311,"eighty":-6.978437,"marketCap":17885556995},{"date":"2025-01-10","current":-5.450117,"twenty":-12.058756,"median":-9.391379,"eighty":-6.644107,"marketCap":14683190599},{"date":"2025-01-17","current":-5.875315,"twenty":-12.04248,"median":-9.241225,"eighty":-6.25569,"marketCap":15841493338},{"date":"2025-01-24","current":-6.177753,"twenty":-11.949888,"median":-9.172529,"eighty":-6.11967,"marketCap":16761321984},{"date":"2025-01-28","current":-6.498305,"twenty":-11.921589,"median":-9.112153,"eighty":-6.130311,"marketCap":17715218357},{"date":"2025-02-07","current":-7.424154,"twenty":-11.872333,"median":-8.96938,"eighty":-6.148709,"marketCap":20134027017},{"date":"2025-02-14","current":-8.323374,"twenty":-11.760531,"median":-8.922014,"eighty":-6.178085,"marketCap":22518767950},{"date":"2025-02-21","current":-10.607329,"twenty":-11.720414,"median":-8.939394,"eighty":-6.187416,"marketCap":28855365285},{"date":"2025-02-28","current":-8.380735,"twenty":-11.643652,"median":-8.964036,"eighty":-6.222464,"marketCap":22723174315},{"date":"2025-03-07","current":-8.409794,"twenty":-11.556185,"median":-8.912474,"eighty":-6.239893,"marketCap":22893512953},{"date":"2025-03-14","current":-8.131514,"twenty":-11.5122,"median":-8.860603,"eighty":-6.269085,"marketCap":22144022946},{"date":"2025-03-21","current":-7.997044,"twenty":-11.440339,"median":-8.816527,"eighty":-6.340941,"marketCap":21769277942},{"date":"2025-03-28","current":-9.307254,"twenty":-11.391935,"median":-8.776023,"eighty":-6.503525,"marketCap":25284615976},{"date":"2025-04-03","current":-13.220486,"twenty":-11.563082,"median":-8.857032,"eighty":-6.524404,"marketCap":21465794803},{"date":"2025-04-11","current":-11.616184,"twenty":-11.563082,"median":-8.876505,"eighty":-6.613619,"marketCap":18692124688},{"date":"2025-04-17","current":-8.481901,"twenty":-11.535495,"median":-8.876505,"eighty":-6.644107,"marketCap":18290143512},{"date":"2025-04-25","current":-9.200975,"twenty":-11.479403,"median":-8.897671,"eighty":-6.665344,"marketCap":19857870099},{"date":"2025-05-02","current":-9.49742,"twenty":-11.434072,"median":-8.939394,"eighty":-6.691701,"marketCap":20541238098},{"date":"2025-05-09","current":-8.545306,"twenty":-11.391935,"median":-8.912474,"eighty":-6.740034,"marketCap":18611728453},{"date":"2025-05-13","current":-8.355545,"twenty":-11.345262,"median":-8.897671,"eighty":-6.784859,"marketCap":18330341630}],"updateTime":1747237240711}}}